FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer
FundaMental Pharma, a neuroscience company developing first-in-class small molecule inhibitors for the treatment of a range of neurodegenerative diseases, announced the appointment of Dr. Dirk Beher as Chief Executive Officer and Executive Board member. Dr. Beher assumes this role from…